4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-25-056331
Options or other derivatives
- Chief Executive Officer acquired 345,672 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brumm Joshua T Chief Executive Officer | 2025-12-08 | Grant or award · Stock Option (Right to Buy) | +345,672 | 345,672 | D | ||
Loading xslF345X05/wk-form4_1765402538.xml…